Growth Metrics

Ultragenyx Pharmaceutical (RARE) Cash from Operations (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -97.34%
Dec 31, 2025 -9.19%
Sep 30, 2025 15.93%
Jun 30, 2025 34.49%
Mar 31, 2025 -109.29%
Dec 31, 2024 -18.39%
Sep 30, 2024 12.95%
Jun 30, 2024 59.65%
Mar 31, 2024 -126.79%
Dec 31, 2023 28.65%
Sep 30, 2023 -1.47%
Jun 30, 2023 25.95%
Mar 31, 2023 -73.64%
Dec 31, 2022 5.25%
Sep 30, 2022 -23.41%
Jun 30, 2022 34.26%
Mar 31, 2022 -116.25%
Dec 31, 2021 8.89%
Sep 30, 2021 8.73%
Jun 30, 2021 58.98%
Mar 31, 2021 -155.15%
Dec 31, 2020 -0.78%
Sep 30, 2020 -170.94%
Jun 30, 2020 191.80%
Mar 31, 2020 -32.08%
Dec 31, 2019 18.61%
Sep 30, 2019 0.63%
Jun 30, 2019 7.01%
Mar 31, 2019 -71.48%
Dec 31, 2018 19.24%
Sep 30, 2018 9.10%
Jun 30, 2018 14.98%
Mar 31, 2018 -9.36%
Dec 31, 2017 -31.99%
Sep 30, 2017 -26.98%
Jun 30, 2017 20.23%
Mar 31, 2017 -28.37%
Dec 31, 2016 -65.87%
Sep 30, 2016 27.51%
Jun 30, 2016 11.67%
Mar 31, 2016 -11.01%
Dec 31, 2015 -32.17%
Sep 30, 2015 -77.16%
Jun 30, 2015 2.19%
Mar 31, 2015 -41.79%
Dec 31, 2014 -12.91%
Sep 30, 2014 -4.76%
Jun 30, 2014 0.87%
Mar 31, 2014 -8.68%
Dec 31, 2013 -44.85%
Sep 30, 2013 19.55%
Jun 30, 2013 -33.28%